
Margin beat hinges on mix, not pricing — ARPP stalls at +2%
HCG · oncology · ARPP stagnation
BSE: 539787
P/L Snapshot
Q1 FY27 · standalone
Shareholding
Pattern breakdown
P/L Trends
(in crores)

HCG · oncology · ARPP stagnation

payor mix · EBITDA margin expansion · volume growth

oncology hospitals · margin expansion · npm improvement
Corporate Events
Board Meeting
The Twenty Eighth (28th) Annual General Meeting ("AGM") of t…
BSE Filing ↗Board Meeting
The Nomination and Remuneration Committee of the Board of Di…
BSE Filing ↗Board Meeting
The meeting of the Board of Directors is scheduled to consid…
BSE Filing ↗Board Meeting
To consider and decide various matters related to the Rights…
BSE Filing ↗Board Meeting
Consider, approve and take on record the Unaudited Financial…
BSE Filing ↗Board Meeting
Consider, approve and take on record the Unaudited Financial…
BSE Filing ↗Board Meeting
Consider, approve and take on record the Unaudited Financial…
BSE Filing ↗Board Meeting
consider and approve the unaudited financial results of the …
BSE Filing ↗